Publication: HNF1α defect influences post-prandial lipid regulation
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
St-Jean, Matthieu, François Boudreau, André C. Carpentier, and Marie-France Hivert. 2017. “HNF1α defect influences post-prandial lipid regulation.” PLoS ONE 12 (5): e0177110. doi:10.1371/journal.pone.0177110. http://dx.doi.org/10.1371/journal.pone.0177110.
Research Data
Abstract
Purpose Hepatocyte nuclear factor 1 alpha (HNF1α) defects cause Mature Onset Diabetes of the Young type 3 (MODY3), characterized by defects in beta-cell insulin secretion. However, HNF1α is involved in many other metabolic pathways with relevance for monogenic or polygenic type 2 diabetes. We aimed to investigate gut hormones, lipids, and insulin regulation in response to a meal test in HNF1α defect carriers (MODY3) compared to non-diabetic subjects (controls) and type 2 diabetes (T2D). Methods: We administered a standardized liquid meal to each participant. Over 6 hours, we measured post-meal responses of insulin regulation (blood glucose, c-peptide, insulin), gut hormones (ghrelin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1) and lipids (non-esterified fatty acids [NEFA] and triglycerides). Results: We found that MODY3 participants had lower insulin secretion indices than controls and T2D participants, showing the expected β-cell defect. MODY3 had similar glycated hemoglobin levels (HbA1c median [IQR]: 6.5 [5.6–7.6]%) compared to T2D (median: 6.6 [6.2–6.9]%; P<0.05). MODY3 had greater insulin sensitivity (Matsuda index: 71.9 [29.6; 125.5]) than T2D (3.2 [4.0; 6.0]; P<0.05). MODY3 experienced a larger decrease in the ratio of NEFA to insulin (NEFA 30–0 / insulin 30–0: -39 [-78; -30] x104) in the early post-prandial period (0–30 minutes) compared to controls and to T2D (-2.0 [-0.6; -6.4] x104; P<0.05). MODY3 had lower fasting (0.66 [0.46; 1.2] mM) and post-meal triglycerides levels compared to T2D (fasting: 2.3 [1.7; 2.7] mM; P<0.05). We did not detect significant post-meal differences in ghrelin and incretins between MODY3 and other groups. Conclusion: In response to a standard meal test, MODY3 showed greater early post-prandial NEFA diminution in response to relatively low early insulin secretion, and they maintained very low post-prandial triglycerides levels.
Description
Other Available Sources
Keywords
Medicine and Health Sciences, Endocrinology, Diabetic Endocrinology, Insulin, Biology and Life Sciences, Biochemistry, Hormones, Peptide Hormones, Ghrelin, Endocrine Disorders, Diabetes Mellitus, Metabolic Disorders, Endocrine Physiology, Insulin Secretion, Physiology, Physical Sciences, Chemistry, Chemical Compounds, Organic Compounds, Carbohydrates, Monosaccharides, Glucose, Organic Chemistry, Lipids, Experimental Organism Systems, Model Organisms, Mouse Models, Animal Models, Biomarkers
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service